The study confirmed that METTL3 facilitates mRNA methylation, increases the stability of SRY transcription factor 2 (SOX2), improves SOX2 protein expression, and contributes to the radiation resistance and maintenance of glioma stem cell-like cells (151). This evidence concerns the gene METTL3 and central nervous system cancer.